Evaluation of real‐world efficacy of mepolizumab on SNOT‐22 outcomes in patients with unified airway disease

Documenti analoghi

• Prevalence and coexistence of type 2 inflammatory diseases
  di: Toni Mora, et al.
  Pubblicazione: (2024)
• Type 2 gene expression signature in severe asthma associates with more advanced airway remodeling
  di: Bogdan Jakiela, et al.
  Pubblicazione: (2025)
• Severe asthmatic airways have distinct circadian clock gene expression pattern associated with WNT signaling
  di: Nguyen Quoc Vuong Tran, et al.
  Pubblicazione: (2024)
• Allergen sensitization patterns: Allergic rhinitis with multimorbidity versus alone—A real‐world study
  di: Ya‐Ting Li, et al.
  Pubblicazione: (2025)
• Real‐world drug use in asthma, chronic obstructive pulmonary disease, rhinitis, cough, and cold in Finland from 1990 to 2021: Association with reduced disease burden
  di: Tiina Mattila, et al.
  Pubblicazione: (2024)